Seton Hall University - Center for Health & Pharmaceutical Law & Policy
Date Written: November 30, 2009
Abstract
This White Paper makes several policy recommendations to eliminate or manage the conflicts of interest that arise pursuant to the compensation arrangements between investigators and their institutions with drug and medical device manufacturers as they affect the recruitment and enrollment of human research subjects in clinical trials. The paper seeks to accomplish overall financial neutrality as between treatment and research, so that physicians' decisions regarding inclusion of patients in clinical trials is unaffected by their own financial interests.
Keywords: conflict of interest, pharmaceutical, clinical trials
Boozang, Kathleen M. and Boozang, Kathleen M. and Coleman, Carl H. and Miller, Tracy E. and Greenwood, Kate and Gutmann Koch, Valerie and Gutmann Koch, Valerie and Handler-Hutchinson, Simone and Finizio, Catherine, Conflicts of Interest in Clinical Trial Recruitment & Enrollment: A Call for Increased Oversight (November 30, 2009). White Paper for the Center for Health & Pharmaceutical Law & Policy, Seton Hall Law School, Available at SSRN: https://ssrn.com/abstract=1515762 or http://dx.doi.org/10.2139/ssrn.1515762
Subscribe to this fee journal for more curated articles on this topic
FOLLOWERS
28
PAPERS
1,599
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Download This Paper